Pilnik Richard D.'s Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Aug 17, 2021
- Accession no.
- 0001235802-21-000100
- Filed
- Aug 17, 2021
- Trade date
- Aug 16, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $49.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pilnik Richard D.CIK 0001760016 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Voting Common Shares, no par value per share | PPurchaseAcquired | +2,500 | $3.21 | +$8,025 | 83,065 | Direct | |
| Aug 16, 2021 | Voting Common Shares, no par value per share | PPurchaseAcquired | +12,500 | $3.28 | +$41,000 | 95,565 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.